040-000-534 N-(2’-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride
| Type | Active Pharmaceutical ingredient |
| CAS No. | 482577-59-3 |
| Chemical Formula | C20H23ClN2O2 |
| Appearance | white powder |
| Packaging | 5g, 25g |
| Assay | ≥98% |
| Related Products | Valsartan, Irbesartan, Olmesartan Medoxomil |
Description
N-(2’-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride Introduction
Moxifloxacin Hydrochloride is a kind of pharmaceutical intermediate for Valsartan. Valsartan is an angiotensin II receptor antagonist antihypertensive drug that blocks the type I (AT1) receptor of angiotensin II, increasing the plasma concentration of angiotensin II. High, stimulate the unblocked AT2 receptors, while counteracting the effect of AT1 receptors, so as to achieve the effect of dilating blood vessels and reducing blood pressure. Valsartan is used in the treatment of hypertension, congestive heart failure, and post-myocardial infarction.
N-(2’-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride Specification
| Appearance | white powder |
| Melting Point | 186℃ |
| Content | 98.0% |
| Storage Condition | Room Temperature |
| Packaging | 5g, 25g |
N-(2’-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride Applications
N-(2’-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride is a pharmaceutical intermediate for Valsartan, which is used in the treatment of hypertension, congestive heart failure, and post-myocardial infarction.
